Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
heartburn
Pharma
Investors sue GSK, claiming company misled them on Zantac
Investors have sued GSK, claiming the company deceived them about its knowledge of a potential carcinogen in its heartburn medicine Zantac.
Kevin Dunleavy
Feb 6, 2025 8:05am
Phathom aims to 'kick some acid' with first Voquezna campaign
Mar 26, 2024 8:00am
FDA signs off on Phathom's Voquezna for 2 stomach disorders
Nov 2, 2023 4:03pm
AZ agrees to $425M settlement in US over heartburn drugs
Oct 3, 2023 10:57am
Plaintiff in first Zantac case in U.S. moves for dismissal
Aug 16, 2022 4:25pm
An industry win for makers of OTC, generic versions of Zantac
Jul 13, 2021 12:07pm
